机译:供体衍生的抗CD19 Car T细胞与因同种异体造血干细胞移植后反复化B-全部的供体淋巴细胞输注相比。
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Department of Hematology Shenzhen People's Hospital Second Clinical Medical College of Jinan;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases the;
机译:异基因造血干细胞移植后复发性血液系统癌患者先后顺序注入供体来源的树突状细胞和供体淋巴细胞
机译:供体来源CAR19 T细胞输注B-全部在同种异体造血干细胞移植后复发
机译:供体来源CAR19 T细胞输注B-全部在同种异体造血干细胞移植后复发
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:I阶段I试验预防性供体衍生的IL-2-活化的NK细胞输注后同种异体造血干细胞移植在匹配的兄弟供体中
机译:pIGa突变导致供体来源的造血干细胞扩增与异基因干细胞移植后晚期移植失败相关。
机译:HLa匹配算法在寻找异基因造血干细胞供体和脐血单元中的比较参考研究。